JP2023529066A5 - - Google Patents
Info
- Publication number
- JP2023529066A5 JP2023529066A5 JP2022568724A JP2022568724A JP2023529066A5 JP 2023529066 A5 JP2023529066 A5 JP 2023529066A5 JP 2022568724 A JP2022568724 A JP 2022568724A JP 2022568724 A JP2022568724 A JP 2022568724A JP 2023529066 A5 JP2023529066 A5 JP 2023529066A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- nanoparticles
- group
- poly
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20174156.8A EP3909612A1 (en) | 2020-05-12 | 2020-05-12 | Composition of nanoparticles |
| EP20174156.8 | 2020-05-12 | ||
| EP20196024.2A EP3909613A1 (en) | 2020-05-12 | 2020-09-14 | Nanoparticles as carrier-system for adjuvants/antigens |
| EP20196024.2 | 2020-09-14 | ||
| PCT/EP2021/062759 WO2021229020A1 (en) | 2020-05-12 | 2021-05-12 | Nanoparticles as carrier-system for adjuvants/antigens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023529066A JP2023529066A (ja) | 2023-07-07 |
| JP2023529066A5 true JP2023529066A5 (enExample) | 2024-05-22 |
Family
ID=70682623
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568554A Pending JP2023524874A (ja) | 2020-05-12 | 2021-05-12 | ナノ粒子の組成物 |
| JP2022568723A Pending JP2023529065A (ja) | 2020-05-12 | 2021-05-12 | Ｈｐｖ由来の免疫原性フラグメントのためのの担体としてのナノ粒子の組成物 |
| JP2022568724A Pending JP2023529066A (ja) | 2020-05-12 | 2021-05-12 | アジュバント／抗原の担体系としてのナノ粒子 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568554A Pending JP2023524874A (ja) | 2020-05-12 | 2021-05-12 | ナノ粒子の組成物 |
| JP2022568723A Pending JP2023529065A (ja) | 2020-05-12 | 2021-05-12 | Ｈｐｖ由来の免疫原性フラグメントのためのの担体としてのナノ粒子の組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (4) | US20230272014A1 (enExample) |
| EP (6) | EP3909612A1 (enExample) |
| JP (3) | JP2023524874A (enExample) |
| WO (3) | WO2021229020A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3909612A1 (en) * | 2020-05-12 | 2021-11-17 | Life Science Inkubator Betriebs GmbH & Co. KG | Composition of nanoparticles |
| CN113274492B (zh) * | 2021-05-21 | 2022-06-17 | 大连理工大学 | 一种基于羟基氧化铝纳米羧基改性的复合疫苗佐剂的制备方法 |
| US20240042070A1 (en) * | 2022-06-28 | 2024-02-08 | Transcode Therapeutics, Inc. | Nanoparticles and template directed rig-i agonist precursor compositions and uses thereof for cancer therapy |
| EP4673166A1 (en) * | 2023-03-02 | 2026-01-07 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Therapeutic hpv vaccines based on validated target epitopes |
| WO2024180234A1 (en) * | 2023-03-02 | 2024-09-06 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Validated hpv16-derived stimulation peptides |
| WO2024180233A1 (en) * | 2023-03-02 | 2024-09-06 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | A therapeutic hpv vaccine based on validated target epitopes |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3616133A1 (de) | 1985-09-25 | 1987-11-19 | Merck Patent Gmbh | Kugelfoermige sio(pfeil abwaerts)2(pfeil abwaerts)-partikel |
| US6419931B1 (en) * | 1991-08-26 | 2002-07-16 | Epimmune Inc. | Compositions and methods for eliciting CTL immunity |
| US6214345B1 (en) | 1993-05-14 | 2001-04-10 | Bristol-Myers Squibb Co. | Lysosomal enzyme-cleavable antitumor drug conjugates |
| DE69425356T2 (de) | 1993-09-22 | 2002-04-18 | Hoechst Ag | Pro-Prodrugs, ihre Herstellung und Anwendung |
| US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
| US6180095B1 (en) | 1997-12-17 | 2001-01-30 | Enzon, Inc. | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| DE19912502A1 (de) * | 1999-03-19 | 2000-09-21 | Inst Neue Mat Gemein Gmbh | Nanoskalige Teilchen, Komplexe mit Polynukleotiden und deren Verwendung |
| NZ517928A (en) | 1999-09-27 | 2004-09-24 | Coley Pharm Gmbh | Methods related to immunostimulatory nucleic acid-induced interferon |
| IL153474A0 (en) * | 2000-06-26 | 2003-07-06 | Stressgen Biotechnologies Corp | Human papilloma virus treatment |
| DE102004011110A1 (de) | 2004-03-08 | 2005-09-22 | Merck Patent Gmbh | Verfahren zur Herstellung monodisperser SiO2-Partikel |
| WO2006017476A2 (en) * | 2004-08-02 | 2006-02-16 | The Research Foundation Of State University Of New York | Amino functionalized ormosil nanoparticles as delivery vehicles |
| WO2006037979A2 (en) | 2004-10-01 | 2006-04-13 | Midatech Limited | Nanoparticles comprising antigens and adjuvants and immunogenic structure |
| JP4981681B2 (ja) | 2004-12-09 | 2012-07-25 | アルナイラム ファーマシューティカルズ， インコーポレイテッド | 哺乳類における免疫応答誘導組成物および方法、ならびに短鎖干渉ｒｎａなどのオリゴヌクレオチド剤に対する免疫応答の回避方法 |
| WO2006070376A1 (en) * | 2004-12-30 | 2006-07-06 | Hadasit Medical Research Services & Development Ltd. | Antimicrobial nanoparticulate additives forming non-leachable sustained antimicrobial polymeric compositions |
| EP1764107A1 (en) | 2005-09-14 | 2007-03-21 | Gunther Hartmann | Compositions comprising immunostimulatory RNA oligonucleotides and methods for producing said RNA oligonucleotides |
| AU2006290567A1 (en) | 2005-09-14 | 2007-03-22 | Ucb Pharma S.A | Comb polymers |
| SI2056845T1 (en) | 2006-08-08 | 2018-02-28 | Rheinische Friedrich-Wilhelms-Universitaet Bonn | STRUCTURE AND USE 5 'PHOSPHATE OF OLIGONUCLEOTES |
| FR2908305B1 (fr) | 2006-11-10 | 2009-02-27 | Oreal | Procede de deformation permanente des fibres keratiniques comprenant une etape d'application d'une composition de rincage intermediaire comprenant un sel de cation metallique monovalent ou un sel d'ammonium et un acide organique |
| JP5448369B2 (ja) * | 2008-05-15 | 2014-03-19 | 古河電気工業株式会社 | 粒子表面にアミノ基を有するシリカ粒子の製造方法、粒子表面にアミノ基を有するシリカ粒子、及びそれを用いた複合粒子 |
| EP2297323A1 (en) | 2008-05-21 | 2011-03-23 | Hartmann, Gunther | 5' triphosphate oligonucleotide with blunt end and uses thereof |
| EP4015636B1 (en) | 2008-05-21 | 2024-11-20 | Rheinische Friedrich-Wilhelms-Universität Bonn | 5' triphosphate oligonucleotide with blunt end and uses thereof |
| DE102008033175A1 (de) | 2008-07-15 | 2010-01-21 | Merck Patent Gmbh | Siliciumdioxid-Nanopartikel und deren Verwendung zur Vakzinierung |
| AU2010225129A1 (en) | 2009-03-17 | 2010-09-23 | Gunther Hartmann | TLR7 ligand and uses thereof |
| ES2366841B1 (es) * | 2010-04-06 | 2013-01-24 | Consejo Superior De Investigaciones Cientificas (Csic) (45%) | Nanoparticulas de silice para difusion intracelular de agentes bioactivos poco solubles |
| AU2011263546B2 (en) | 2010-06-10 | 2015-01-22 | Midatech Limited | Peptide-carrying nanoparticles |
| DE102011018499A1 (de) * | 2011-04-23 | 2012-10-25 | Emc Microcollections Gmbh | Topische Nanopartikel-Vakzine zur Immunstimulation der dendritischen Zellen in der Haut |
| AU2012306243B2 (en) | 2011-09-07 | 2016-10-20 | Midatech Limited | Nanoparticle-peptide compositions |
| MX2014002764A (es) | 2011-09-07 | 2014-12-04 | Midatech Ltd | Vacunas en nanoparticulas para tumor. |
| EP2883550A1 (en) | 2013-12-12 | 2015-06-17 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Novel promiscuous HPV16-derived T helper epitopes for immunotherapy |
| EP3134124B1 (en) | 2014-04-25 | 2019-02-20 | Pierre Fabre Medicament | Igf-1r antibody-drug-conjugate and its use for the treatment of cancer |
| US11786469B2 (en) * | 2014-07-22 | 2023-10-17 | Cheolhee WON | Silica nanoparticle composition for delivering bioactive material or protein such as a human proteasome |
| WO2016054225A1 (en) * | 2014-09-30 | 2016-04-07 | Stc.Unm | Plasmid delivery in the treatment of cancer and other disease states |
| EP3370741B1 (en) * | 2015-11-04 | 2025-10-08 | The Trustees of the University of Pennsylvania | Methods and compositions for gene editing in hematopoietic stem cells |
| KR102317281B1 (ko) * | 2015-11-17 | 2021-10-25 | 하이라이트 테라퓨틱스 에스.엘. | 이본쇄 폴리리보뉴클레오타이드 및 폴리알킬렌이민의 복합체를 포함하는 입자를 포함하는 신규 약제학적 조성물 |
| WO2017223085A2 (en) * | 2016-06-20 | 2017-12-28 | The Regents Of The University Of Michigan | Compositions and methods for delivery of biomacromolecule agents |
| WO2018085751A1 (en) | 2016-11-07 | 2018-05-11 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Development of agonist epitopes of the human papillomavirus |
| US20200375912A1 (en) * | 2017-08-03 | 2020-12-03 | Rita Elena Serda | Liposomal coated nanoparticles for immunotherapy applications |
| GB201718817D0 (en) * | 2017-11-14 | 2017-12-27 | N4 Pharma Uk Ltd | Particulate material production process |
| US20210196838A1 (en) * | 2018-08-24 | 2021-07-01 | Mirexus Biotechnologies Inc. | Compounds and compositions for potentiation of tlr agonists |
| EP3909612A1 (en) * | 2020-05-12 | 2021-11-17 | Life Science Inkubator Betriebs GmbH & Co. KG | Composition of nanoparticles |
-
2020
- 2020-05-12 EP EP20174156.8A patent/EP3909612A1/en not_active Withdrawn
- 2020-09-14 EP EP20196024.2A patent/EP3909613A1/en not_active Withdrawn
- 2020-09-14 EP EP20196027.5A patent/EP3909614A1/en not_active Withdrawn
-
2021
- 2021-05-12 US US17/924,193 patent/US20230272014A1/en active Pending
- 2021-05-12 EP EP21724703.0A patent/EP4149561A1/en active Pending
- 2021-05-12 US US17/998,318 patent/US20240197909A1/en not_active Abandoned
- 2021-05-12 JP JP2022568554A patent/JP2023524874A/ja active Pending
- 2021-05-12 WO PCT/EP2021/062759 patent/WO2021229020A1/en not_active Ceased
- 2021-05-12 WO PCT/EP2021/062751 patent/WO2021229015A1/en not_active Ceased
- 2021-05-12 JP JP2022568723A patent/JP2023529065A/ja active Pending
- 2021-05-12 WO PCT/EP2021/062748 patent/WO2021229014A1/en not_active Ceased
- 2021-05-12 EP EP21725179.2A patent/EP4149562A1/en active Pending
- 2021-05-12 EP EP21724702.2A patent/EP4149560A1/en active Pending
- 2021-05-12 US US17/924,258 patent/US20230181727A1/en active Pending
- 2021-05-12 JP JP2022568724A patent/JP2023529066A/ja active Pending
-
2025
- 2025-06-27 US US19/252,301 patent/US20260000754A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023529065A5 (enExample) | ||
| JP2023524874A5 (enExample) | ||
| CN108046276B (zh) | 一种羧基封端的聚乙二醇修饰的介孔二氧化硅纳米颗粒的制备及其用途 | |
| Sarmento et al. | Development and comparison of different nanoparticulate polyelectrolyte complexes as insulin carriers | |
| Stasko et al. | Dendrimers as a scaffold for nitric oxide release | |
| AU2002229065B2 (en) | Compositions containing inclusion complexes | |
| Shi et al. | Heparin-reduced graphene oxide nanocomposites for curcumin delivery: in vitro, in vivo and molecular dynamics simulation study | |
| CN103690961B (zh) | 一种智能两亲性聚合物纳米胶束及其制备方法和应用 | |
| JP5480912B2 (ja) | 水に対する溶解度の低い活性薬剤を含む組成物 | |
| CN108210932B (zh) | 一种电荷驱动自组装壳聚糖基载药纳米粒子的制备方法 | |
| Kumar et al. | In-vitro and in-vivo study of indomethacin loaded gelatin nanoparticles | |
| Lin et al. | Preparation of surface-modified albumin nanospheres | |
| CN103372217B (zh) | 聚合物纳米载体制剂及其制备方法和应用 | |
| Shinde et al. | Design and characterization of chitosan-alginate microspheres for ocular delivery of azelastine | |
| JP2018503736A5 (enExample) | ||
| JP2018525462A5 (enExample) | ||
| Zhu et al. | Self‐Assembling Stereocomplex Nanoparticles by Enantiomeric Poly (γ‐glutamic acid)‐poly (lactide) Graft Copolymers as a Protein Delivery Carrier | |
| Rezaei Mokarram et al. | Preparation and evaluation of chitosan nanoparticles containing Diphtheria toxoid as new carriers for nasal vaccine delivery in mice | |
| JPWO2020162323A5 (enExample) | ||
| Tiwari et al. | Synthesis and characterization of dendro-PLGA nanoconjugate for protein stabilization | |
| Munir et al. | Dendrimers and their applications: a review article | |
| Patel et al. | Solubility of aceclofenac in polyamidoamine dendrimer solutions | |
| AU2008248602B2 (en) | Modified-release particles based on polyelectrolytes and on an active principle and pharmaceutical formulations containing these particles | |
| Hasnain et al. | Carbon nanotubes in vaccine delivery | |
| EP2651394A1 (fr) | Nanoparticules comportant au moins un actif et au moins deux polyelectrolytes |